INR 1456.8
(-2.39%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.72 Billion INR | -31.89% |
2022 | 3.58 Billion INR | 19.76% |
2021 | 2.99 Billion INR | -16.28% |
2020 | 3.57 Billion INR | -2.74% |
2019 | 3.67 Billion INR | 12.93% |
2018 | 3.25 Billion INR | 6.73% |
2017 | 3.05 Billion INR | 18.18% |
2016 | 2.58 Billion INR | 2.76% |
2015 | 2.51 Billion INR | 5.39% |
2014 | 2.38 Billion INR | 17.4% |
2013 | 2.03 Billion INR | 16.63% |
2012 | 1.74 Billion INR | 22.72% |
2011 | 1.41 Billion INR | 13.04% |
2010 | 1.25 Billion INR | 22.72% |
2009 | 1.02 Billion INR | 17.6% |
2008 | 870.06 Million INR | 38.21% |
2007 | 629.52 Million INR | -14.95% |
2006 | 740.21 Million INR | 11.56% |
2005 | 663.5 Million INR | 15.87% |
2004 | 572.64 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 691.01 Million INR | 31.84% |
2024 Q2 | 1.02 Billion INR | -9.28% |
2023 Q4 | 524.12 Million INR | -45.54% |
2023 Q3 | 962.48 Million INR | 0.38% |
2023 FY | 2.44 Billion INR | -31.89% |
2023 Q1 | 1.1 Billion INR | 35.05% |
2023 Q2 | 958.81 Million INR | -12.97% |
2022 Q2 | 856.23 Million INR | -13.83% |
2022 Q4 | 815.79 Million INR | -11.54% |
2022 FY | 3.58 Billion INR | 19.76% |
2022 Q1 | 993.66 Million INR | 617.42% |
2022 Q3 | 922.23 Million INR | 7.71% |
2021 Q2 | 1.1 Billion INR | 11.59% |
2021 Q1 | 991.12 Million INR | 9.33% |
2021 Q3 | 1.09 Billion INR | -1.37% |
2021 FY | 2.99 Billion INR | -16.28% |
2021 Q4 | -192.04 Million INR | -117.61% |
2020 Q4 | 906.56 Million INR | -10.84% |
2020 Q2 | 929.91 Million INR | 28.25% |
2020 FY | 3.57 Billion INR | -2.74% |
2020 Q1 | 725.09 Million INR | -7.88% |
2020 Q3 | 1.01 Billion INR | 9.34% |
2019 Q3 | 965.79 Million INR | 3.28% |
2019 FY | 3.67 Billion INR | 12.93% |
2019 Q4 | 787.1 Million INR | -18.5% |
2019 Q2 | 935.13 Million INR | -5.67% |
2019 Q1 | 991.32 Million INR | 42.53% |
2018 Q4 | 695.51 Million INR | -11.56% |
2018 FY | 3.25 Billion INR | 6.73% |
2018 Q3 | 786.38 Million INR | -9.88% |
2018 Q2 | 872.55 Million INR | -3.45% |
2018 Q1 | 903.74 Million INR | 36.13% |
2017 Q3 | 706.9 Million INR | 7.55% |
2017 Q4 | 663.89 Million INR | -6.08% |
2017 FY | 3.05 Billion INR | 18.18% |
2017 Q1 | 717.12 Million INR | 40.05% |
2017 Q2 | 657.25 Million INR | -8.35% |
2016 Q3 | 621.85 Million INR | -7.94% |
2016 Q4 | 512.04 Million INR | -17.66% |
2016 Q1 | 752.37 Million INR | 29.54% |
2016 Q2 | 675.47 Million INR | -10.22% |
2016 FY | 2.58 Billion INR | 2.76% |
2015 Q2 | 648.39 Million INR | -4.57% |
2015 Q4 | 580.8 Million INR | -6.05% |
2015 FY | 2.51 Billion INR | 5.39% |
2015 Q1 | 679.44 Million INR | 15.1% |
2015 Q3 | 618.22 Million INR | -4.65% |
2014 Q1 | 632.77 Million INR | 20.89% |
2014 FY | 2.38 Billion INR | 17.4% |
2014 Q4 | 590.33 Million INR | 1.94% |
2014 Q3 | 579.1 Million INR | -3.2% |
2014 Q2 | 598.22 Million INR | -5.46% |
2013 Q4 | 523.43 Million INR | 5.18% |
2013 FY | 2.03 Billion INR | 16.63% |
2013 Q3 | 497.63 Million INR | 3.7% |
2013 Q2 | 479.87 Million INR | -14.1% |
2013 Q1 | 558.66 Million INR | 14.57% |
2012 FY | 1.74 Billion INR | 22.72% |
2012 Q2 | 417.99 Million INR | -6.24% |
2012 Q1 | 445.81 Million INR | 20.26% |
2012 Q4 | 487.62 Million INR | 18.12% |
2012 Q3 | 412.82 Million INR | -1.24% |
2011 Q4 | 370.72 Million INR | 10.6% |
2011 Q3 | 335.18 Million INR | 0.0% |
2011 FY | 1.41 Billion INR | 13.04% |
2010 FY | 1.25 Billion INR | 22.72% |
2009 FY | 1.02 Billion INR | 17.6% |
2008 FY | 870.06 Million INR | 38.21% |
2007 FY | 629.52 Million INR | -14.95% |
2006 FY | 740.21 Million INR | 11.56% |
2005 FY | 663.5 Million INR | 15.87% |
2004 FY | 572.64 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott India Limited | 5.98 Billion INR | 37.834% |
Cipla Limited | 59.21 Billion INR | 93.716% |
Gland Pharma Limited | 14.65 Billion INR | 74.609% |
GlaxoSmithKline Pharmaceuticals Limited | 4.35 Billion INR | 14.596% |
Kopran Limited | 1.41 Billion INR | -162.845% |
Marksans Pharma Limited | 3.28 Billion INR | -13.13% |
NGL Fine-Chem Limited | 1.75 Billion INR | -112.618% |
Pfizer Limited | 4.33 Billion INR | 14.199% |
Sanofi India Limited | 4.13 Billion INR | 9.938% |
SMS Pharmaceuticals Limited | 769.2 Million INR | -383.792% |